Law Offices of Howard G. Smith continues its investigation on behalf of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) investors concerning the Company’s possible violations of federal securities laws.

In June 2021, LifeStance completed its initial public offering (“IPO”), issuing 32.8 million shares at $18 per share. On August 11, 2021, LifeStance announced its second quarter 2021 financial results, reporting a net loss of $70 million.

On this news, the Company’s stock price fell $10.16, or 46%, to close at $11.71 per share on August 12, 2021, thereby injuring investors.

Then, on November 8, 2021, after the market closed, LifeStance announced its third quarter 2021 financial results, reporting net loss of $120.5 million compared to a net loss of $3.3 million the prior year.

On this news, the Company’s stock price fell $3.10, or 24%, to close at $9.73 per share on November 9, 2021, thereby injuring investors further.

If you purchased LifeStance securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006658/en/